Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07 2021 - 4:05PM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage
genetic medicines company committed to delivering life-changing
treatments for people battling devastating diseases, announced
today that Paul Bolno, MD, MBA, President and Chief Executive
Officer, is scheduled to give a pre-recorded presentation at the
H.C. Wainwright 23rd Annual Global Investment Conference, which
will be made available for on-demand viewing on Monday,
September 13, 2021 at 7:00 a.m. ET.
A webcast of the presentation will be available on the Investor
Relations page of the Wave Life Sciences corporate
website at http://ir.wavelifesciences.com. A replay of
the presentation will be archived and available at that site for 90
days following the event.
About Wave Life Sciences Wave Life
Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines
company committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization,
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please
visit www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Sep 2023 to Sep 2024